PDIA3 rs2788: An Independent Risk Factor for Hypertension and Its Interaction With Antihypertensive Medications
ABSTRACT Hypertension is a multifactorial condition influenced by both genetic and environmental factors. Protein disulfide isomerase family A member 3 (PDIA3) is a key endoplasmic reticulum protein which may contribute to increased blood pressure. However, the relationship between PDIA3 polymorphis...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | The Journal of Clinical Hypertension |
Subjects: | |
Online Access: | https://doi.org/10.1111/jch.14959 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832576446525079552 |
---|---|
author | Hongtao Lan Yingbin Xi Baoxu Kang Zhoujie Tong Jie Peng Wei Zhang Ming Zhong Huiping Gong Zhihao Wang |
author_facet | Hongtao Lan Yingbin Xi Baoxu Kang Zhoujie Tong Jie Peng Wei Zhang Ming Zhong Huiping Gong Zhihao Wang |
author_sort | Hongtao Lan |
collection | DOAJ |
description | ABSTRACT Hypertension is a multifactorial condition influenced by both genetic and environmental factors. Protein disulfide isomerase family A member 3 (PDIA3) is a key endoplasmic reticulum protein which may contribute to increased blood pressure. However, the relationship between PDIA3 polymorphisms and hypertension remain unclear. This study aims to explore the relationship between PDIA3 polymorphisms and hypertension. First, Mendelian randomization (MR) analyses were performed to assess the causal link between PDIA3 and hypertension. Second, key gene polymorphism on PDIA3 was identified using online databases and analyzed with Haploview software. Third, multivariate‐adjusted logistic regression analyses were employed to evaluate the associations between PDIA3 rs2788 and hypertension. Finally, stratified analyses were conducted to further assess interactions between PDIA3 rs2788 and antihypertensive medications. MR analyses indicated a causal relationship between PDIA3 and hypertension. The rs2788 gene polymorphism locus on PDIA3 was identified using online databases and Haploview software. Multivariable‐adjusted logistic regression analyses revealed that PDIA3 rs2788 was an independent risk for hypertension (OR: 4.603, 95% CI: 2.946–7.194; p < 0.001). Significant interactions were identified between PDIA3 and antihypertensive medications, particularly ACEI/ARB treatments (p = 0.013 for interaction). Similar findings were observed regarding the causal relationship between antihypertensive treatments and hypertension. PDIA3, particularly its rs2788 polymorphisms, may represent a novel biomarker for hypertension. These findings may contribute to the development of targeted screening strategies and personalized treatment approaches for hypertension management. |
format | Article |
id | doaj-art-e9ed8055097e4614a190249edd581451 |
institution | Kabale University |
issn | 1524-6175 1751-7176 |
language | English |
publishDate | 2025-01-01 |
publisher | Wiley |
record_format | Article |
series | The Journal of Clinical Hypertension |
spelling | doaj-art-e9ed8055097e4614a190249edd5814512025-01-31T05:38:36ZengWileyThe Journal of Clinical Hypertension1524-61751751-71762025-01-01271n/an/a10.1111/jch.14959PDIA3 rs2788: An Independent Risk Factor for Hypertension and Its Interaction With Antihypertensive MedicationsHongtao Lan0Yingbin Xi1Baoxu Kang2Zhoujie Tong3Jie Peng4Wei Zhang5Ming Zhong6Huiping Gong7Zhihao Wang8National Key Laboratory for Innovation and Transformation of Luobing Theory, The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical SciencesDepartment of CardiologyQilu Hospital of Shandong UniversityJinanChinaInternal Medicine Departmentthe Affiliated Weihai Second Municipal Hospital of Qingdao UniversityWeihaiChinaNational Key Laboratory for Innovation and Transformation of Luobing Theory, The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical SciencesDepartment of CardiologyQilu Hospital of Shandong UniversityJinanChinaNational Key Laboratory for Innovation and Transformation of Luobing Theory, The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical SciencesDepartment of CardiologyQilu Hospital of Shandong UniversityJinanChinaNational Key Laboratory for Innovation and Transformation of Luobing Theory, The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical SciencesDepartment of CardiologyQilu Hospital of Shandong UniversityJinanChinaNational Key Laboratory for Innovation and Transformation of Luobing Theory, The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical SciencesDepartment of CardiologyQilu Hospital of Shandong UniversityJinanChinaNational Key Laboratory for Innovation and Transformation of Luobing Theory, The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical SciencesDepartment of CardiologyQilu Hospital of Shandong UniversityJinanChinaDepartment of EmergencyThe Second Hospital, Cheeloo College of Medicine, Shandong UniversityJinanChinaNational Key Laboratory for Innovation and Transformation of Luobing Theory, The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical SciencesDepartment of CardiologyQilu Hospital of Shandong UniversityJinanChinaABSTRACT Hypertension is a multifactorial condition influenced by both genetic and environmental factors. Protein disulfide isomerase family A member 3 (PDIA3) is a key endoplasmic reticulum protein which may contribute to increased blood pressure. However, the relationship between PDIA3 polymorphisms and hypertension remain unclear. This study aims to explore the relationship between PDIA3 polymorphisms and hypertension. First, Mendelian randomization (MR) analyses were performed to assess the causal link between PDIA3 and hypertension. Second, key gene polymorphism on PDIA3 was identified using online databases and analyzed with Haploview software. Third, multivariate‐adjusted logistic regression analyses were employed to evaluate the associations between PDIA3 rs2788 and hypertension. Finally, stratified analyses were conducted to further assess interactions between PDIA3 rs2788 and antihypertensive medications. MR analyses indicated a causal relationship between PDIA3 and hypertension. The rs2788 gene polymorphism locus on PDIA3 was identified using online databases and Haploview software. Multivariable‐adjusted logistic regression analyses revealed that PDIA3 rs2788 was an independent risk for hypertension (OR: 4.603, 95% CI: 2.946–7.194; p < 0.001). Significant interactions were identified between PDIA3 and antihypertensive medications, particularly ACEI/ARB treatments (p = 0.013 for interaction). Similar findings were observed regarding the causal relationship between antihypertensive treatments and hypertension. PDIA3, particularly its rs2788 polymorphisms, may represent a novel biomarker for hypertension. These findings may contribute to the development of targeted screening strategies and personalized treatment approaches for hypertension management.https://doi.org/10.1111/jch.14959antihypertensives medicationshypertensionPDIA3single nucleotide polymorphisms |
spellingShingle | Hongtao Lan Yingbin Xi Baoxu Kang Zhoujie Tong Jie Peng Wei Zhang Ming Zhong Huiping Gong Zhihao Wang PDIA3 rs2788: An Independent Risk Factor for Hypertension and Its Interaction With Antihypertensive Medications The Journal of Clinical Hypertension antihypertensives medications hypertension PDIA3 single nucleotide polymorphisms |
title | PDIA3 rs2788: An Independent Risk Factor for Hypertension and Its Interaction With Antihypertensive Medications |
title_full | PDIA3 rs2788: An Independent Risk Factor for Hypertension and Its Interaction With Antihypertensive Medications |
title_fullStr | PDIA3 rs2788: An Independent Risk Factor for Hypertension and Its Interaction With Antihypertensive Medications |
title_full_unstemmed | PDIA3 rs2788: An Independent Risk Factor for Hypertension and Its Interaction With Antihypertensive Medications |
title_short | PDIA3 rs2788: An Independent Risk Factor for Hypertension and Its Interaction With Antihypertensive Medications |
title_sort | pdia3 rs2788 an independent risk factor for hypertension and its interaction with antihypertensive medications |
topic | antihypertensives medications hypertension PDIA3 single nucleotide polymorphisms |
url | https://doi.org/10.1111/jch.14959 |
work_keys_str_mv | AT hongtaolan pdia3rs2788anindependentriskfactorforhypertensionanditsinteractionwithantihypertensivemedications AT yingbinxi pdia3rs2788anindependentriskfactorforhypertensionanditsinteractionwithantihypertensivemedications AT baoxukang pdia3rs2788anindependentriskfactorforhypertensionanditsinteractionwithantihypertensivemedications AT zhoujietong pdia3rs2788anindependentriskfactorforhypertensionanditsinteractionwithantihypertensivemedications AT jiepeng pdia3rs2788anindependentriskfactorforhypertensionanditsinteractionwithantihypertensivemedications AT weizhang pdia3rs2788anindependentriskfactorforhypertensionanditsinteractionwithantihypertensivemedications AT mingzhong pdia3rs2788anindependentriskfactorforhypertensionanditsinteractionwithantihypertensivemedications AT huipinggong pdia3rs2788anindependentriskfactorforhypertensionanditsinteractionwithantihypertensivemedications AT zhihaowang pdia3rs2788anindependentriskfactorforhypertensionanditsinteractionwithantihypertensivemedications |